Terray Therapeutics, a biotechnology company, has closed $60 million in Series A financing. Madrona Venture Group led the round with participation from other investors that include Two Sigma Ventures, Digitalis Ventures, KdT Ventures, Goldcrest Capital, XTX Ventures, Sahsen Ventures, Greentrail Capital and Alexandria Venture Investments.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: